INTERLEUKIN-2 IN THERAPY OF HEMATOLOGIC MALIGNANCIES

被引：0
|
作者：
SZNOL, M [1 ]
PARKINSON, DR [1 ]
机构：
[1] NCI,DIV CANC TREATMENT,CANC THERAPY EVALUAT PROGRAM,INVEST DRUG BRANCH,EPN 715,ROCKVILLE,MD 20852
来源：
BLOOD | 1994年 / 83卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2020 / 2022
页数：3
相关论文
共 50 条
  • [31] Overview of interleukin-2 inhalation therapy
    Huland, E
    Heinzer, H
    Huland, H
    CANCER JOURNAL, 2000, 6 : S104 - S112
  • [32] Immunotoxin therapy of hematologic malignancies
    Frankel, AE
    Neville, DM
    Bugge, TA
    Kreitman, RJ
    Leppla, SH
    SEMINARS IN ONCOLOGY, 2003, 30 (04) : 545 - 557
  • [33] Vaccine therapy in hematologic malignancies
    Avigan, David
    Rosenblatt, Jacalyn
    BLOOD, 2018, 131 (24) : 2640 - 2650
  • [34] Subcutaneous administration of interleukin-2 triggers Fcγ receptor I expression on human peripheral blood neutrophils in solid and hematologic malignancies
    Sconocchia, G
    Cococcetta, NY
    Campagnano, L
    Amadori, S
    Iorio, B
    Boffo, V
    Ferdinandi, V
    Del Principe, I
    Adorno, D
    Casciani, CU
    JOURNAL OF IMMUNOTHERAPY, 2001, 24 (04): : 374 - 383
  • [35] Gene therapy of hematologic malignancies
    Wierda, WG
    Kipps, TJ
    SEMINARS IN ONCOLOGY, 2000, 27 (05) : 502 - 511
  • [36] Antiangiogenic therapy in hematologic malignancies
    Moehler, TM
    Hillengass, J
    Goldschmidt, H
    Ho, AD
    CURRENT PHARMACEUTICAL DESIGN, 2004, 10 (11) : 1221 - 1234
  • [37] CONTINUOUS-INFUSION OF INTERLEUKIN-2 IN CHILDREN WITH REFRACTORY MALIGNANCIES
    RIBEIRO, RC
    RILL, D
    ROBERSON, PK
    FURMAN, WL
    PRATT, CB
    BRENNER, M
    CRIST, WM
    PUI, CH
    CANCER, 1993, 72 (02) : 623 - 628
  • [38] Bcl-2 antisense therapy in hematologic malignancies
    Chanan-Khan, A
    CURRENT OPINION IN ONCOLOGY, 2004, 16 (06) : 581 - 585
  • [39] Immunotherapy with interleukin-2 after hematopoietic cell transplantation for hematologic malignancy
    Margolin, K
    Forman, SJ
    CANCER JOURNAL, 2000, 6 : S33 - S38
  • [40] INFLUENCE OF SCHEDULE OF INTERLEUKIN-2 ADMINISTRATION ON THERAPY WITH INTERLEUKIN-2 AND LYMPHOKINE ACTIVATED KILLER CELLS
    THOMPSON, JA
    LEE, DJ
    LINDGREN, CG
    BENZ, LA
    COLLINS, C
    SHUMAN, WP
    LEVITT, D
    FEFER, A
    CANCER RESEARCH, 1989, 49 (01) : 235 - 240
12345